INSIGHTS ON PHARMACEUTICAL PACKAGING
-
Why Compounding Pharma Manufacturers Should Evaluate BFS Systems
Discover how BFS technology offers compounding pharmacies and 503B facilities enhanced sterility, reduced errors, cost savings, and superior product integrity for aseptic pharmaceutical manufacturing.
-
Blister Solutions
With over 6,000 tooling parts and an in-house machining center to ensure precision, explore this versatile blister service that provides both Thermoformed and Cold-Formed solutions.
-
Material Transfer Into A Cleanroom: How To Reduce Contamination Risk At Every Step
Evaluate packaging integrity and master wiping techniques to prevent cleanroom contamination. Focus on surface coverage and controlled transfer paths to ensure consistent product safety and quality.
-
West Vantage™ Goes Beyond Contract Manufacturing
Successfully advancing a drug-delivery device to market demands more than technical expertise; it requires coordinated execution, regulatory insight, and the ability to scale without disruption.
-
Find Flexibility And Scalability With Modular Assembly Equipment9/30/2025
Find tailor-made solutions designed to deliver high-quality standards even when scaling up. Modularity enhances production efficiency, saves costs, and shortens time to market.
-
Clinical, Commercial Packaging: Delivering Next-Gen Therapies4/7/2026
See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.
-
Overcome Common Pre-Filled Syringe Challenges Through Partnership5/23/2025
The pre-filled syringe space is one of the fastest growing pharma sectors, offering greater patient safety and lower manufacturing costs. But pre-filled doesn’t translate to easily filled; there are particular obstacles to overcome.
-
Supporting GLP-1 And Peptides With Integrated Solutions9/30/2025
Accelerate GLP-1 and peptide therapy development with integrated drug containment, delivery, machinery, and analytics for reliable combination product performance.
-
FAQs On The Revised EU GMP Annex 1: Volume 13/5/2025
The revised GMP Annex 1 guidelines emphasize quality risk management, enhanced environmental monitoring, and data integrity, which aim to minimize contamination and ensure patient safety.
PHARMACEUTICAL PACKAGING SOLUTIONS
-
Finding a strategic CDMO partner that will offer tailored solutions for your late phase clinical and commercial needs, mitigate risks, and bolster your supply chain is crucial for meeting project milestones on time.
-
Integrated aseptic manufacturing services support late‑stage clinical and commercial ophthalmic drug products through flexible filling, packaging, testing, and scale‑up capabilities.
-
Once material is packaged, secondary packaging is a crucial part of the preparation process. Ropack doesn’t leave anything to chance, with secondary contract packaging services to ensure your products are ready for market when you need them to be.
-
From start to finish, NovaPure components have been designed and manufactured using Quality by Design principles to mitigate risk for the patient.
-
Referenced in the new USP <1207> Chapter Guidance as a deterministic test method for container closure integrity testing.